BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16105068)

  • 21. Effects of recombinant human endostatin on peritoneal angiogenesis in peritoneal dialysis rats.
    Zhao ZZ; Cao Y; Liu ZS; Xiao J; Tang L; Wang P; Liang XH
    Nephrology (Carlton); 2011 Aug; 16(6):599-606. PubMed ID: 21457400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
    Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
    J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations.
    Vrtovsnik F; Coester AM; Lopes-Barreto D; de Waart DR; Van der Wal AC; Struijk DG; Krediet RT; Zweers MM
    Perit Dial Int; 2010; 30(5):558-69. PubMed ID: 20421431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
    Nagaraj RH; Sarkar P; Mally A; Biemel KM; Lederer MO; Padayatti PS
    Arch Biochem Biophys; 2002 Jun; 402(1):110-9. PubMed ID: 12051689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution.
    Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F
    Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
    Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C
    J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis.
    Combet S; Miyata T; Moulin P; Pouthier D; Goffin E; Devuyst O
    J Am Soc Nephrol; 2000 Apr; 11(4):717-728. PubMed ID: 10752531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological inhibition of heparin-binding EGF-like growth factor promotes peritoneal angiogenesis in a peritoneal dialysis rat model.
    Li Z; Yan H; Yuan J; Cao L; Lin A; Dai H; Ni Z; Qian J; Fang W
    Clin Exp Nephrol; 2018 Apr; 22(2):257-265. PubMed ID: 28710535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats.
    Breborowicz A; Połubinska A; Wu G; Tam P; Oreopoulos DG
    Blood Purif; 2006; 24(3):274-81. PubMed ID: 16465047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients.
    Gao D; Zhao ZZ; Liang XH; Li Y; Cao Y; Liu ZS
    Nephrology (Carlton); 2011 Nov; 16(8):736-42. PubMed ID: 21771176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats.
    Breborowicz A; Polubinska A; Moberly J; Ogle K; Martis L; Oreopoulos D
    Am J Kidney Dis; 2001 Mar; 37(3):594-600. PubMed ID: 11228185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
    Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
    Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal hyaluronan administration in conscious rats: absorption, metabolism, and effects on peritoneal fluid dynamics.
    Breborowicz A; Polubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Moberly J; Martis L; Oreopoulos D
    Perit Dial Int; 2001; 21(2):130-5. PubMed ID: 11330555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.
    Kihm LP; Müller-Krebs S; Klein J; Ehrlich G; Mertes L; Gross ML; Adaikalakoteswari A; Thornalley PJ; Hammes HP; Nawroth PP; Zeier M; Schwenger V
    J Am Soc Nephrol; 2011 May; 22(5):914-26. PubMed ID: 21511829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation.
    Pawlaczyk K; Polubinska A; Numata N; Nakayama M; Pecoits-Filho R; Czekalski S; Lindholm B; Breborowicz A
    Int J Artif Organs; 2008 Jun; 31(6):535-44. PubMed ID: 18609506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia.
    Miyata T; Izuhara Y; Sakai H; Kurokawa K
    Perit Dial Int; 1999; 19 Suppl 2():S58-61. PubMed ID: 10406495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in rats.
    Duman S; Sen S; Sozmen EY; Oreopoulos DG
    Int J Artif Organs; 2005 Feb; 28(2):170-6. PubMed ID: 15770605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.